Publication Highlights
About Our Lab
The Bunyavanich Lab combines tools in epidemiology, multi-omics, and systems biology to study asthma and allergic diseases in human cohorts. Our goal is to better understand and identify risk factors, mechanisms, and potential therapies for these disorders. We are based at the Department of Genetics and Genomic Sciences and Department of Pediatrics at the Icahn School of Medicine at Mount Sinai in New York, NY. We contribute as leaders and members of many NIH-supported asthma and allergy research networks. The Bunyavanich Lab leads the NIH-supported Systems Biology of Early Atopy (SunBEAm) Analysis & Bioinformatics Center.
Unraveling Mechanisms of Allergen Sensitization and Allergic Rhinitis via the Nasal Transcriptome. Yoon Y, Chun Y, Zhang L, Grishina G, Grishin A, Bunyavanich S. Journal of Allergy and Clinical Immunology. 2025 Sep 17. doi: 10.1016/j.jaci.2025.08.028.
Nasal gene expression of angiotensin-converting enzyme 2 in children and adults. Bunyavanich S, Do A, Vicencio A. JAMA, 2020 May 20; 323(23):2427-9.
Principal Investigator
Supinda Bunyavanich, MD, MPH, MPhil Mount Sinai Endowed Professor in Allergy & Systems Biology Deputy Director, Jaffe Food Allergy Institute Icahn School of Medicine at Mount Sinai, New York, NY supinda (dot) bunyavanich (at) mssm.edu
Positions available:
Machine learning-driven identification of early-life air toxic combinations associated with childhood asthma outcomes.
Li Y, Hsu H, Chun Y, Chiu P, Arditi Z, Claudio L, Pandey G, Bunyavanich S. Journal of Clinical Investigation. 2021 Nov 15;131(22):e152088.
Integrative transcriptomic analysis reveals key drivers of acute peanut allergic reactions. Watson C, Cohain A, et al., Schadt E, Bunyavanich S. Nature Communications, 2017 Dec; 8(1):1943.